• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Influenza
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Influenza trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Influenza research

Signant Health has helped sponsors deliver successful multinational vaccine trials, most notably for COVID-19. Study teams can count on our solutions and scientific expertise to help them overcome unique challenges of vaccine development and generate reliable safety and efficacy data, streamline study workflows, and improve the participant experience.

Why Signant Health

  • Collect Reliable PROs
  • Simplify Global Participation
  • Optimize Supply Management
  • Select the Right Outcome Measures
  • Improve Patient Adherence
  • Digitize the Process
  • Collect Reliable PROs

    Collect Reliable PROs

    Our eCOA platform includes a built-in reactogenicity diary instrument for collecting PRO data, and embedded alerts to help patients adhere to assessment requirements.
     
     
     
     
     

  • Simplify Global Participation

    Simplify Global Participation

    Make it easier for patients to participate in your study no matter where they are located by enabling remote consent and reconsent.
     
     
     
     

  • Optimize Supply Management

    Optimize Supply Management

    Our RTSM solution can handle complex randomization schemes and mid-study protocol amendments with ease. Plus, optimize the shelf life of hard-to-produce vaccines by directing medication only to where it’s needed in your study.
     
     
     

  • Select the Right Outcome Measures

    Select the Right Outcome Measures

    Our Science and Medicine team has hundreds of years in combined clinical research experience, and our in-house infectious disease expert has over 25 years of experience in the field. Consult with them on selecting proper eligibility criteria, endpoints, and data quality management strategies.
     
     
     
     
     

  • Improve Patient Adherence

    Improve Patient Adherence

    Improve patient comprehension, adherence, and overall retention in your study by enabling convenient video assessments and remote access to study information at-home with Patient Concierge, a module of our eCOA.
     
     
     
     
     

  • Digitize the Process

    Digitize the Process

    Each solution and service within our Signant SmartSignals evidence generation platform can be applied to a study independently. However, when combined, they create an intuitive and powerful digital ecosystem for creating and managing complex global studies. Plus, every study is supported by a dedicated team of clinical science and operations experts.
     
     
     
     
     

Comprehensive Influenza experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Influenza trial resources
SOLUTION BROCHURE

Influenza Trial Solutions Overview



GET INSIGHTS
VIDEO

Influenza Trial Solutions




WATCH [2 MIN]
CASE STUDY

Global Pharmaceutical Company Enables Remote Sample Collection with Signant’s eCOA Solution 

 
READ CASE STUDY

eClinical solutions for Influenza trials

Ready to learn more?

Discover how Signant can support your current or upcoming influenza trials. 

DOWNLOAD BROCHURE GET STARTED